Pricing & Access· June 24, 2026 · 26 min read
Roche Genentech Portfolio Dossier: Subcutaneous Biologic Transitions
By Ran Chen#Purple Book#Biosimilars#J-Code
Topic
HCPCS Coding
Healthcare Common Procedure Coding System codes, biosimilar Q-codes, J-codes, buy-and-bill billing, and reimbursement.
Generics· June 22, 2026 · 19 min read
Generic Lanreotide Acetate: 505(b)(2) Approvals and Medical-Benefit Coding
By Ran Chen#Generics#FDA Approval#Orange Book
Pricing & Access· June 21, 2026 · 6 min read
Bicillin L-A Shortage: FDA's Lentocilin Importation and Billing Guidance
Generics· June 21, 2026 · 10 min read
Generic Sandostatin LAR Depot: CGT Exclusivity, Supply Shocks, and Buy-and-Bill Economics
By Ran Chen#Generics#Orange Book#HCPCS Coding
Pricing & Access· June 13, 2026 · 15 min read
NDC lookup for claims teams: reading labeler, product, and package codes before you bill
By Ran Chen#HCPCS Coding#Reimbursement#Pharmacy Benefit
Pricing & Access· May 31, 2026 · 12 min read
Biosimilar HCPCS and NDC crosswalk errors that deny claims
By Ran Chen#Biosimilars#HCPCS Coding#Payer Coverage
Pricing & Access· May 31, 2026 · 13 min read
Retina buy-and-bill inventory risk when payer preference changes
By Ran Chen#Anti-VEGF#Ophthalmology#Buy and Bill
Pipeline· May 31, 2026 · 10 min read
Veligrotug vs Tepezza thyroid eye disease access guide
By Ran Chen#PDUFA Date#FDA Approval#Ophthalmology
Pricing & Access· May 30, 2026 · 11 min read
Datroway TNBC coverage guide: TROP2 ADC access and coding
By Ran Chen#ADC#Breast Cancer#Prior Authorization
Pricing & Access· May 29, 2026 · 10 min read
Tecentriq Hybreza bladder cancer MRD access guide
By Ran Chen#Oncology#PD-L1#Companion Diagnostic